Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis c infect
PH11998002411B1Inactive Publication Date: 2018-09-16MERCK SHARP & DOHME CORP
0 Cites 0 Cited by
Patent Information
- Application Number
- PH11998002411
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 1998-09-16
- Publication Date
- 2018-09-16
- Estimated Expiration
- Not applicable · inactive patent
Abstract
There is disclosed the use of ribavirin, interferon alpha or a combination of ribavirin and interferon alpha for the manufacture of a pharmaceutical composition for treating a patient having chronic hepatitis C infection to eradicate detectable HCV-RNA b
Need to check novelty before this filing date? Find Prior Art